Abstract
Introduction

27
Most cancer deaths are due to metastasis of the primary tumor, which complicates treatment 28 and promotes relapse [1] [2] [3] . Circulating tumor cells (CTC) are bloodborne enablers of metas-29 tasis that can be isolated and genetically characterized [4, 5] . Counts of single CTCs have 30 been used to predict tumor progression [6, 7] and monitor curative and palliative therapies in 31 breast [8, 9] and lung cancers [10] . CTCs have also been isolated in clusters of 2-30 cells [11] . 32 These CTC clusters, though rare, are associated with more aggressive metastatic cancer and 33 poorer survival rates in mice and breast and prostate cancer patients [5] . 34 Cellular growth within tumors follows Darwinian evolution with sequential accumulation 35 of mutations and selection resulting in subclones of different fitness [12, 13] . Certain classes 36 of mutations are known to give cancer cells advantages beyond local growth rates. For 37 example, acquiring mutations in ANGPTL4 in breast tumors does not appear to provide a 38 growth advantage to cells in the primary, however it enhances metastatic potential to the 39 lungs [14] . Similarly, breast tumors are more likely to metastasize into the lung or brain if 40 they acquire mutations in TGFβ or ST6GALNAC5, respectively [14, 15] . These mutations 41 are referred to as metastasis progression genes or metastasis virulence genes [1, 16] . 42 Mutations, including metastasis progression and virulence genes, are not uniformly dis-43 tributed in the tumor. Tumors show substantial intratumoral heterogeneity (ITH) [17] [18] [19] 44 where subclones have private mutations that can lead to subclonal phenotypes [20] [21] [22] and 45 contribute to therapy resistance and relapse [3, 23] . Studying ITH is therefore important for 46 cancer treatment and prognosis [23] [24] [25] . This requires multiple samples across a tumor to 47 capture the complete mutational spectrum of a primary tumor.
48
Next-generation sequencing (NGS) of single CTCs has shown that they have similar 49 genetic composition to both the primary and metastatic lesions [26] . This opens the way 50 for using CTC and CTC clusters as a non-invasive liquid biopsy to study tumors, monitor 51 response to therapy, and determine patient-specific course of treatment [26] [27] [28] [29] .
52
Here we ask whether genetic heterogeneity within individual circulating tumor cell clusters 53 can be informative about solid tumor progression. Because CTC clusters are thought to 54 originate from neighboring cells in the tumor [5] , heterogeneity within CTC clusters is closely 55 related to cellular-scale genetic heterogeneity within tumors. Here, we therefore suppose that 56 CTC cluster diversity is a direct function of diversity in small cell clusters within the tumor. 57 We study the interplay of tumor dynamics, CTC cluster diversity, and metastatic outlook 58 through large-scale tumor modelling. We show that fine-scale tumor heterogeneity, and 59 therefore CTC cluster composition, depend sensitively on the tumor growth dynamics and 60 sampling location. Simulated data is consistent with recent sequencing experiments, but 61 slightly finer sampling will provide stringent tests that distinguish between state-of-the-art 62 models. These findings further reinforce the utility of fine-scale tumor profiling and CTC 63 clusters as clinical tools to elucidate tumor information and clinical outlook [30, 31] .
64
Tumor growth model
65
To simulate the growth of solid tumors, we use TumorSimulator [32] . The software is able to 66 simulate a tumor containing 10 8 − 10 9 cells, or roughly 2 cubic centimeters, in 24 core-hours. 67 The tumor consists of cells that occupy a 3D lattice. Empty lattice sites are assumed to 68 contain normal cells which are not modelled in TumorSimulator.
69
Each cell has an associated list of genetic alterations which represent single nucleotide 70 polymorphisms (SNPs) that can be either passenger or driver. Driver mutations increase the 71 growth rate by a factor 1 + s, where s ≥ 0 is the average selective advantage of a driver 72 mutation.
73
At t = 0, the simulation begins with a single cell that already has an unlimited growth 74 potential. The TumorSimulator algorithm then proceeds to grow the tumor through the 75 following steps: 76 1. Select a random cell to be the mother cell. k , where b is the initial tumor birth rate, s is 78 the average selective advantage of a driver mutation, and k is the number of driver 79 mutations present in the mother cell. 5. Kill (i.e., remove) the mother cell with probability proportional to the death rate d. The birth rate (b = ln(2)), and selective advantage (s = 1%) were kept consistent with 96 [32] . In addition to varying the turnover model (full, surface, or none), we vary its intensity 97 by controlling the death rate, d ∈ {0.05, 0.1, 0.2, 0.65}. TumorSimulator also has a parameter 98 that controls migration of cells to form new independent cancer lesions. We did not allow 99 such local migrations, as they would have little effect on the very fine-scale diversity in the 100 primary tumor. We tried two values for the passenger mutation rate: λ p = 0.02 to facilitate 101 comparison with simulations from [32] , and λ p = 0.0375 to match experimental observations 102 from [34] .
103
CTC cluster synthesis
104
Experimental evidence suggests that CTC clusters are formed from neighboring cells in the 105 primary tumor and not by agglomeration or proliferation of single CTCs in the blood [5, 35] . 106 To represent circulating tumor cell clusters, we therefore sampled spherical clusters of cells 107 in different areas of the tumor. We varied the number of cells in the cluster from 2 to 30 to 108 allow comparison to empirical findings [11] .
109
Results
110
Global composition
111
To determine the effect of the growth dynamics on global intra-tumor heterogeneity, we first 112 consider the allele frequency spectra for different turnover models (Fig 1, S1) . In all cases, a 113 majority of driver and passenger genetic variants are at frequency less than 1%, as expected 114 from theoretical and empirical observations [36] . Passenger mutations represent the bulk 115 of ITH, consistent with the theoretical and experimental evidence that neutral evolution 116 drives most ITH [37] . For simulations with low to moderate death rate, d = {0.05, 0.1, 0.2}, 117 we find that the frequency spectra are indistinguishable between the three turnover models 118 (Fig 1, S1) (a) At low death rate, the frequency spectra are indistinguishable, whereas for (b) higher death rate, the turnover model produces elevated diversity across the frequency spectrum for both driver and neutral mutations.
When the death rate is increased to d = 0.65, as in [32] , the different models produce 120 distinct frequency spectra (Fig 1b) . As in [32] , we find that the number of high-frequency 121 drivers is higher in the turnover model than in the no turnover model. Whereas [32] inter-122 preted this observation as an indication that turnover reduces diversity, we find that diversity 123 is in fact increased for all types of variants and at all frequencies. The number of somatic 124 mutations in the turnover model is 3.4 times higher than in the surface turnover model and 125 6.2 times higher than in the no turnover model. This is primarily due to a higher number 126 of cell divisions required to reach a given tumor size when cell death occurs throughout the 127 tumor (Table S1 ). The Waclaw et al model uses a death rate of d = 0.65, which is a stag-128 gering 95% of the birth rate. The turnover model therefore has 8.3 times more cell divisions 129 to reach a given size, and the surface turnover has 4 times more cell divisions than the no 130 turnover model (Table S1 ).
131
Cluster diversity depends on sampling position and turnover rate 132
To study the effect of cluster size, position of origin, and evolutionary model on CTC cluster 133 composition, we sampled groups of cells across tumors. To assess genetic heterogeneity within 134 clusters, we consider the number of distinct somatic mutations, S(n), among cells in clusters 135 of size n.
136
As expected, we find that larger CTC clusters have more somatic mutations (Fig 2, S2) . 137 By contrast with global diversity patterns, we find that moderate turnover has a profound 138 impact: Clusters from models with low turnover have many more somatic mutations than 139 in the no turnover model (Fig 2a,b) . Surface turnover has little effect on cluster diversity 140 (Fig S2) . A higher number of somatic mutations increases the likelihood that a metastatic progression mutation is present. The number of mutations in single CTCs increases at the edge, reflecting the larger number of cell divisions. The trend is reversed for larger clusters with at higher death rate. The shaded gray area represents the density of tumor cells at each position. The smoothed curves were obtained by a Gaussian weighted average using weight
, with x i is the distance from the centre of the tumor. Fig 2 also shows the relationship between a CTC cluster's shedding location (i.e. its 142 distance to the tumor center-of-mass when it was sampled) and its genetic content. No 143 turnover and surface turnover models show similar trends of increasing diversity with distance 144 (Fig S2) . Full turnover models show an opposite trend of decreasing diversity with distance 145 in clusters of intermediate size (Fig 2b-d and S3 for d ∈ {0.1, 0.2} and {0.65}, respectively). 146 However, these trends revert again when considering large clusters with thousands of cells 3. 147 Comparison with multi-region sequencing data
148
To validate predictions of our model, we used multi-region sequencing data from a Hepato-149 cellular Carcinoma (HCC) patient presented in [34] (Fig 3a) . The HCC data contained 23 150 sequenced samples each with ≈ 20, 000 cells, therefore we used our sampling scheme that 151 produces CTCs to produce 23 biopsies of comparable sizes (20, 000 cells). The distance 152 measurements were made using ImageJ [38] and Fig S1 from [34] . Since [34] could only 153 reliably call variants at more than 10% frequency, we used a similar frequency cutoff in our 154 simulations. Interestingly, even though the spatial trend in diversity are undetectable in 155 large clusters (Fig S6) , they are restored if we impose a frequency cutoff (Fig 3c, d) . The 156 spatial trends therefore strongly depends on our choice of sample size and frequency cutoff 157 (Fig S6) , with low cutoff showing weaker spatial patterns. For large samples and low cutoffs, 158 the large number of rare, recent variants overwhelms the signal for older common variants. 159 Such trends are similar across turnover models (Fig 2c, d ) and are barely detectable with the 160 current sample size (Fig 3b) . The trends observed in the HCC data (Fig 3a) are consistent 161 with these but not sigificant. Fig 3b shows the number of different samples necessary to reliably identify spatial trends. 163 For biopsies containing tens of thousands of cells, the number of spatially distributed samples 164 needed is ≈ 40, roughly twice the size of the HCC dataset. Furthermore, these show similar 165 qualitative trends for both models, with an increase in diversity at the edge (Fig 3b and 166  S7) . Alternatively, ≈ 30 small cluster (23-30 cells) samples are necessary to detect spatial 167 patterns. Furthermore, intermediate-sized clusters show qualitatively opposite trends in the 168 different models (Fig 3b and S7) . Thus small cluster sequencing may increase our power in 169 discriminating between leading models.
170
CTC clusters derived from turnover models are more likely to con-171 tain virulent mutations
172
Metastasis is an inefficient process [4] in that most CTCs are eliminated from the circu-173 latory system or fail to survive in the new microenvironment. We hypothesize that the 174 genetic composition of CTC clusters influences the likelihood of implantation into a new mi-175 croenvironment. More specifically, genetic heterogeneity within a cluster may contribute to 176 implantation by increasing the likelihood that a metastasis progression mutation is present. 177 If a cluster has S somatic mutations, and each mutation has a small probability p 1 of 178 being a metastasis progression or virulence gene, the probability of having at least one such 179 metastasis virulence gene is 1 − (1 − p) S ≈ Sp.
180
Diverse CTC clusters do not carry more virulent mutations, on average, than homoge-181 neous ones, but they are more likely to carry some virulent mutations because of the increased 182 diversity. Unless implantation probability is exactly proportional to the number of cells car-183 rying virulent mutations in a cluster, which seems unlikely, diversity will impact implantation 184 rate.
185
To compare the increased likelihood that CTC clusters possess metastatic progression 186 genes compared to single CTCs, we determine the relative increase in the number of distinct 187 somatic mutations in a CTC cluster versus a single CTC, i.e., A(n) = S(n) S(1) − 1, where S(n) 188 is the number of somatic mutations in a cluster of size n. We refer to A(n) as the cluster 189 advantage. A higher cluster advantage indicates that a CTC cluster is more potent relative 190 to a single CTC from the same tumor. In other words, a higher cluster advantage means less 191 genetic redundancy within a cluster. To disentangle the contributions from the microscopic 192 and macroscopic diversity, as well as cluster size effects, we compute the cluster advantage 193 for clusters composed of neighboring cells, as well as for random sets of cells sampled across 194 the tumor (Fig 4) . Whereas randomly sampled sets of cells show similar and almost linear increase of the 196 cluster advantage with sample size, cell clusters show more variability. Turnover models have 197 the highest cluster advantage, followed by the surface turnover model, and the no turnover 198 model (Fig 4) . Higher turnover increases the cluster advantage (Fig S4) . Even low turnover 199 with at a death rate of d = 0.05 doubles the cluster advantage compared to the no turnover 200 and surface turnover model (Fig S4) .
201
Discussion
202
Even though the results of our simulations are consistent with Waclaw et al. at the tumor-203 wide level [32] , we reach opposite conclusions about the effect of cell turnover on genetic 204 diversity. Waclaw et al. argued that turnover reduces diversity based on the observation that 205 more high-frequency variants were observed in the tumor with turnover: A small number 206 of clones make up a larger proportion of the tumor. Even though we can reproduce the 207 observation, we find that turnover models in fact vastly increase diversity according to more 208 conventional metrics, for example by increasing the number of segregating mutations across 209 the frequency spectrum. Both the increase in dominant clone frequency and increased overall 210 diversity have the same simple origin: A tumor model with turnover requires more cell 211 divisions to reach a given size. An early driver mutation has more time to realize a selective 212 advantage and occupy a high fraction of the tumor, but carrier cells are also more likely to 213 accumulate new mutations along the way leading to increased diversity ( Figure 1 and Table 214  S1 ).
215
The impact of turnover on cellular heterogeneity is particularly pronounced when con-216 sidering small cell clusters. These fine-scale patterns, observed in Figs 2 and S2, can be 217 interpreted by considering the expansion dynamics of each model and their impact on cell 218 division and mixing. In all turnover models, the number of somatic mutations in a given cell 219 is ≈ 2.75× higher at the edges than at the center of the tumor, reflecting the higher number 220 of divisions to reach the edge: The center of the tumor is occupied early, which slows down 221 cell division. In the no turnover and surface turnover models, cell clusters show the same overall pattern 223 of additional diversity at tumor edge. In the turnover model, however, we observe the opposite 224 pattern: Even though edge cells still carry the most mutations, core clusters are now more 225 diverse than edge clusters.
226
Turnover increases diversity by increasing the number of cell divisions required to reach 227 a given size, especially in the core. More cell divisions lead to more somatic mutations in 228 single cells: core cells in the model with d = 0.2 have ≈ 3.99 somatic mutations, compared 229 to ≈ 1.83 for the no turnover model. However, this has only a modest effect on the spatial 230 patterns of diversity: without turnover, the number of somatic mutations per cell is 3.5 times 231 higher at the edge than in the core, and the ratio is reduced to 2.2 when turnover is present 232 (d = 0.2).
233
More importantly for diversity, turnover allows for mixing of cells from nearby clones 234 (Fig 5c) . This mixing has a smaller effect at the edge of the tumor, where the range expansion 235 produces serial bottlenecks which reduce the effective population size relative to the tumor 236 core. For moderate cluster sizes, this differential mixing effect overwhelms the "number 237 of divisions" effect, and core clusters are much more diverse than edge clusters, producing 238 distinctive gradients of diversity.
239
The difference in somatic diversity between single CTCs and CTC clusters, measured 240 through the cluster advantage, follows the expected law of diminishing returns: the more cells 241 in the cluster, the fewer the number of unique mutations per cell. However, the trends vary 242 by growth model and cluster origin. Cell mixing afforded by turnover reduces neighboring 243 cell similarity and increases cluster advantage.
244
Under the assumption that the presence or absence of a metastatic progression allele 245 modulates metastatic potential of tumor cell clusters, the proportion of metastatic lesions 246 that derive from circulating tumor cell clusters is highest in the turnover model. We can 247 think of this as interference occurring between cells within a cluster. Alternately, this is 248 an illustration of the advantage of not putting all one's egg in the same basket, applied 249 to tumor metastasis: Assuming that there is a chance component to cluster implantation, 250 mixing increases the likelihood that at least one virulence cell makes it to a hospitable site. 251 Such an effect should be robust to details of the growth model.
252
In experiments, CTC clusters derived from primary breast and prostate tumors produced 253 more aggressive metastatic tumors [5] compared to single CTCs. This is likely due to differ-254 ences in mechanical properties of the cluster or the creation of a locally favorable environment 255 by the cluster, rather than by genetic differences. However, the present analysis suggests that 256 this advantage can be enhanced by diversity within the cluster.
257
Both fine-scale mixtures of cell phenotypes and clonally constrained mutations have been 258 observed experimentally in tumors [17, 20] . Similarly, multi-region sequencing revealed high 259 tumor heterogeneity in clear cell renal carcinoma (ccRCC) [22] , but low levels in lung adeno-260 carcinomas [21] . This strongly suggests that the amount of migration and mixing varies sub-261 stantially across tumors, with ccRCC data being better described by a model with turnover, 262 whereas lung adenocarcinoma data more closely resembles a model with low or no turnover. 263 Distinguishing between migration effects, turnover effects, and tumor growth idiosyn-264 crasies is obviously challenging. Among limitations of our model, we note the assumption of 265 spherical tumor shape and the absence of complex physical contraints (which HCC tumors 266 may experience). Another limitation of the present model is the rigid computational grid 267 which prevents cells from pushing each other out of the way, which constrains growth rate 268 in the center of the tumor. This constraint plays a role in reducing diversity at the center of 269 the tumor, but it may not be realistic in the earlier stages of tumor growth.
270
The importance of such effects is largely unknown, and it is likely to vary between tumors 271 and tumor types. Fortunately, we have shown that we are at the cusp of being able to test 272 such models quantitatively. A sampling experiment with twice as many samples than were 273 collected in the HCC patient studied above would enable us to either validate or reject the 274 current state-of-the-art models (Fig 3b) , and sequencing of small clusters would further allow 275 us to discriminate between the different models studied here. The HCC data is from whole 276 exome sequencing, as are most deep tumor sequencing datasets. We expect that power would 277 be further increased in a whole-genome sequencing experiment, however, we were unable to 278 perform whole-genome simulations due to memory constraints.
279
Future data collection schemes including the lung TRACERx study [24] will help us put 280 the state-of-the-art models to the test and identify such important parameters of tumor 281 growth. Given our power analysis, we find that sequencing small contiguous cell clusters 282 provides a richer picture of tumor dynamics compared to larger biopsies, with little to no 283 loss in power, provided that few-cell sequencing can be performed accurately.
284
This work set out to answer two simple questions: First, should we expect substantial 285 heterogeneity at the cellular scale within tumors and within circulating tumor cell clusters? 286 The answer to the first question is most likely yes, as even the models with no turnover 287 exhibit measurable cluster heterogeneity.
288
The second question was whether this heterogeneity, sampled through liquid biopsies or 289 multi-region sequencing, is informative about tumor dynamics. Given that state-of-the-art 290 models produce very different predictions about the level of cluster heterogeneity, the answer 291 is also positive. This work identified some of the key factors that determine cluster diversity, 292 especially the interaction between range expansion, cell turnover, and mixing. Even if no 293 diversity were observed at all in CTC clusters, it would enable us to reject the present 294 models in favor of models including additional biological factors that favor the clustering 295 of genetically similar cells. Measuring diversity, or the lack of diversity, within circulating 296 tumor cell clusters or fine-scale multi-region sequencing is therefore a promising tool for both 297 fundamental and medical oncology. No Turnover (f>10%) Significance Threshold = 0.01 size=1 size=(2,7) size= (8, 12) size= (13, 17) size= (18, 22) size=(23,30) size=100 size=1000 size=10000
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Supporting Information
Supplementary Figure 7: The number of samples necessary to detect spatial trends from a regression analysis for CTCs and biopsies in the no turnover model.
